Related references
Note: Only part of the references are listed.A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients
Hubert D. Lau et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients
Yeonjoo Choi et al.
CANCER RESEARCH AND TREATMENT (2019)
Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC)
Emily Chan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Incidence of succinate dehydrogenase and fumarate hydratase deficient renal cell carcinoma based on immunohistochemical, screening with SDHA/SDHB and FH/2SC
Sounak Gupta et al.
HUMAN PATHOLOGY (2019)
Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases
Xiuyi Pan et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures
Inkeun Park et al.
BMC UROLOGY (2019)
Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience
Joseph T. Rabban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration
Marie Muller et al.
MODERN PATHOLOGY (2018)
A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma
Steven C. Smith et al.
HISTOPATHOLOGY (2017)
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers
M. Muller et al.
CLINICAL GENETICS (2017)
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome
Kiril Trpkov et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients
Nancy M. Joseph et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
Sean R. Williamson et al.
MODERN PATHOLOGY (2015)
Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry
Carolina Reyes et al.
MODERN PATHOLOGY (2014)
Rare insights into cancer biology
J. Adam et al.
ONCOGENE (2014)
Morphologic and Molecular Characteristics of Uterine Leiomyomas in Hereditary Leiomyomatosis and Renal Cancer (HLRCC) Syndrome
Julian Sanz-Ortega et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer-Targeting the Warburg Effect in Cancer
W. Marston Linehan et al.
CLINICAL CANCER RESEARCH (2013)
Structural basis of fumarate hydratase deficiency
Sarah Picaud et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
Chiara Bardella et al.
JOURNAL OF PATHOLOGY (2011)
Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene
Sarah L. Housley et al.
HISTOPATHOLOGY (2010)
The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome
Maria J. Merino et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Diffuse and segmental variants of cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature
Sadhanna Badeloe et al.
EXPERIMENTAL DERMATOLOGY (2006)
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma
MR Morris et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology
M Kiuru et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Inherited susceptibility to uterine leiomyomas and renal cell cancer
V Launonen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
